Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study (Q43406843)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 May 2011
edit
Language Label Description Also known as
English
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study
scientific article published on 16 May 2011

    Statements

    Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study (English)
    Mohamed Hassanein
    Wasim Hanif
    Waqar Malik
    Ali Kamal
    Parnia Geransar
    Nicola Lister
    Chris Andrews
    Anthony Barnett
    16 May 2011
    1367-1374

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit